Oxidative Stress Is Differentially Present in Multiple Sclerosis Courses, Early Evident, and Unrelated to Treatment

Table 2

Demographic and clinical data of MS population.

	PP	SP	RR	BB
𝑁	20	22	32	13
F/M	7/13	13/9	22/10	10/3	𝜒=0.05
Mean age	45.7	45.4	40.7	47.2	𝑃=0.13
Mean EDSS	4.7	5.3	1.3	1.2	𝑃<0.001
No therapy	17	15	12	9	𝜒<0.001
IFNB/GA	1	3	19	4
Other drugs	2	4	1	0

PP: primary progressive; SP: secondary progressive; RR: relapsing-remitting; BB: benign; HC. Other drugs: azathioprine, natalizumab, and low dose naltrexone.